Yoko Ogata

845 total citations
20 papers, 543 citations indexed

About

Yoko Ogata is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yoko Ogata has authored 20 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Yoko Ogata's work include HIV Research and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Epigenetics and DNA Methylation (2 papers). Yoko Ogata is often cited by papers focused on HIV Research and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Epigenetics and DNA Methylation (2 papers). Yoko Ogata collaborates with scholars based in Japan, United States and Canada. Yoko Ogata's co-authors include Hideo Baba, Takatsugu Ishimoto, Masaaki Iwatsuki, Naoya Yoshida, Yuji Miyamoto, Kosuke Mima, Yukiharu Hiyoshi, Yoshifumi Baba, Takamasa Ueno and Xiaomei T. Kuang and has published in prestigious journals such as Journal of Virology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Yoko Ogata

20 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Ogata Japan 13 248 142 113 109 98 20 543
Adam Master Poland 12 245 1.0× 104 0.7× 122 1.1× 28 0.3× 119 1.2× 35 664
Asen Bagashev United States 15 300 1.2× 123 0.9× 170 1.5× 178 1.6× 87 0.9× 27 685
Rebecca Kohnken United States 12 243 1.0× 109 0.8× 113 1.0× 20 0.2× 62 0.6× 38 577
Viola Borgdorff United Kingdom 10 454 1.8× 59 0.4× 55 0.5× 69 0.6× 122 1.2× 10 629
Shujuan Pan United States 16 414 1.7× 53 0.4× 112 1.0× 23 0.2× 106 1.1× 32 668
Rachel A. Cleary United States 10 203 0.8× 50 0.4× 139 1.2× 217 2.0× 31 0.3× 13 571
Mercè Pérez‐Riba Spain 15 559 2.3× 115 0.8× 109 1.0× 20 0.2× 43 0.4× 29 736
Henriette Burlet France 14 340 1.4× 109 0.8× 65 0.6× 21 0.2× 72 0.7× 20 643
Lielian Zuo China 14 404 1.6× 199 1.4× 72 0.6× 20 0.2× 241 2.5× 17 618

Countries citing papers authored by Yoko Ogata

Since Specialization
Citations

This map shows the geographic impact of Yoko Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Ogata more than expected).

Fields of papers citing papers by Yoko Ogata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Ogata. The network helps show where Yoko Ogata may publish in the future.

Co-authorship network of co-authors of Yoko Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Ogata. A scholar is included among the top collaborators of Yoko Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Ogata. Yoko Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uemura, Norio, Hiromitsu Hayashi, Zhao Liu, et al.. (2023). Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD-L1 expression in pancreatic cancer.. PubMed. 13(5). 2041–2054. 13 indexed citations
2.
Liu, Zhao, Hiromitsu Hayashi, Yoko Ogata, et al.. (2022). Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer. British Journal of Cancer. 128(5). 844–856. 19 indexed citations
3.
Hayashi, Hiromitsu, Norio Uemura, Yoko Ogata, et al.. (2022). Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma. Translational Oncology. 26. 101533–101533. 12 indexed citations
4.
Nakao, Yosuke, Shigeki Nakagawa, Yo‐ichi Yamashita, et al.. (2021). High ARHGEF2 (GEF-H1) Expression is Associated with Poor Prognosis Via Cell Cycle Regulation in Patients with Pancreatic Cancer. Annals of Surgical Oncology. 28(8). 4733–4743. 8 indexed citations
5.
Sakamoto, Yuki, Kosuke Mima, Takatsugu Ishimoto, et al.. (2021). Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis. Cancer Science. 112(11). 4470–4477. 62 indexed citations
6.
Mima, Kosuke, Yuki Sakamoto, Keisuke Kosumi, et al.. (2019). Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma. Surgical Oncology. 32. 63–68. 22 indexed citations
7.
Kiyozumi, Yuki, Yoshifumi Baba, Kazuo Okadome, et al.. (2019). Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer. Cancer Science. 110(6). 1863–1871. 11 indexed citations
8.
Sawayama, Hiroshi, Yoko Ogata, Takatsugu Ishimoto, et al.. (2019). Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer. Cancer Science. 110(5). 1705–1714. 61 indexed citations
9.
Shimada, Hiroshi, Yuki Kiyozumi, Yoko Ogata, et al.. (2019). A novel cholinesterase assay for the evaluation of neurotoxin poisoning based on the electron-transfer promotion effect of thiocholine on an Au electrode. Sensors and Actuators B Chemical. 298. 126893–126893. 12 indexed citations
10.
Kiyozumi, Yuki, Masaaki Iwatsuki, Junji Kurashige, et al.. (2018). PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. International Journal of Cancer. 143(5). 1202–1211. 33 indexed citations
11.
Miyake, Keisuke, Yoshifumi Baba, Takatsugu Ishimoto, et al.. (2018). Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma. Medical Oncology. 36(1). 11–11. 6 indexed citations
12.
Imamura, Yu, Masayuki Watanabe, Tasuku Toihata, et al.. (2018). Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients. Digestion. 99(1). 6–13. 30 indexed citations
13.
Arima, Kota, Yoshihiro Komohara, Luke Bu, et al.. (2017). Downregulation of 15‐hydroxyprostaglandin dehydrogenase by interleukin‐1β from activated macrophages leads to poor prognosis in pancreatic cancer. Cancer Science. 109(2). 462–470. 37 indexed citations
14.
Toyoda, Mako, Yoko Ogata, Yosuke Maeda, et al.. (2015). Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors. Journal of Virology. 89(18). 9639–9652. 21 indexed citations
15.
Mwimanzi, Philip, Tristan J. Markle, Eric S. Martin, et al.. (2013). Attenuation of multiple Nef functions in HIV-1 elite controllers. Retrovirology. 10(1). 1–1. 68 indexed citations
16.
Mwimanzi, Philip, Tristan J. Markle, Yoko Ogata, et al.. (2013). Dynamic range of Nef functions in chronic HIV-1 infection. Virology. 439(2). 74–80. 28 indexed citations
17.
Mwimanzi, Philip, Tristan J. Markle, Yoko Ogata, et al.. (2011). Impairment of viral replication capacity by nef alleles from HIV elite controllers. Retrovirology. 8(S2). 2 indexed citations
18.
Itokawa, Masanari, Makoto Arai, Yoko Ogata, et al.. (2003). Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neuroscience Letters. 347(3). 202–204. 61 indexed citations
19.
Ito, Yuji, et al.. (1999). Analysis of a catalytic pathway via a covalent adduct of D52E hen egg white mutant lysozyme by further mutation. Protein Engineering Design and Selection. 12(4). 327–331. 6 indexed citations
20.
Inada, Toshiya, et al.. (1997). 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice.. PubMed. 17(3C). 1965–71. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Master Breakdown of academic impact, for papers by Asen Bagashev Breakdown of academic impact, for papers by Rebecca Kohnken Breakdown of academic impact, for papers by Viola Borgdorff Breakdown of academic impact, for papers by Shujuan Pan Breakdown of academic impact, for papers by Rachel A. Cleary Breakdown of academic impact, for papers by Mercè Pérez‐Riba Breakdown of academic impact, for papers by Henriette Burlet Breakdown of academic impact, for papers by Lielian Zuo
Rankless by CCL
2026